Does the media prefer BRKR or MTD?

In the previous week, Bruker had 4 more articles in the media than Mettler-Toledo International. MarketBeat recorded 15 mentions for Bruker and 11 mentions for Mettler-Toledo International. Mettler-Toledo International's average media sentiment score of 1.27 beat Bruker's score of 1.18 indicating that Mettler-Toledo International is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Bruker 10 Very Positive mention(s) 0 Positive mention(s) 4 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Mettler-Toledo International 9 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Does the media prefer RGEN or MTD?

In the previous week, Repligen had 29 more articles in the media than Mettler-Toledo International. MarketBeat recorded 40 mentions for Repligen and 11 mentions for Mettler-Toledo International. Mettler-Toledo International's average media sentiment score of 1.27 beat Repligen's score of 1.00 indicating that Mettler-Toledo International is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Repligen 22 Very Positive mention(s) 4 Positive mention(s) 10 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Positive Mettler-Toledo International 9 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Does the media refer more to MTD or TECH?

In the previous week, Bio-Techne had 4 more articles in the media than Mettler-Toledo International. MarketBeat recorded 15 mentions for Bio-Techne and 11 mentions for Mettler-Toledo International. Bio-Techne's average media sentiment score of 1.41 beat Mettler-Toledo International's score of 1.27 indicating that Bio-Techne is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Mettler-Toledo International 9 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Bio-Techne 12 Very Positive mention(s) 1 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Does the media prefer BIO or MTD?

In the previous week, Mettler-Toledo International had 2 more articles in the media than Bio-Rad Laboratories. MarketBeat recorded 11 mentions for Mettler-Toledo International and 9 mentions for Bio-Rad Laboratories. Bio-Rad Laboratories' average media sentiment score of 1.34 beat Mettler-Toledo International's score of 1.27 indicating that Bio-Rad Laboratories is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Bio-Rad Laboratories 7 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Mettler-Toledo International 9 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Mettler-Toledo International (MTD) Competitors

$1,392.58 +56.29 (+4.21%)

Closing price 07/28/2026 03:59 PM Eastern

Extended Trading

$1,389.00 -3.58 (-0.26%)

As of 07/28/2026 04:49 PM Eastern

Compare

MTD vs. BRKR, RGEN, TECH, A, and BIO

Should you buy Mettler-Toledo International stock or one of its competitors? MarketBeat compares Mettler-Toledo International with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with Mettler-Toledo International include Bruker (BRKR), Repligen (RGEN), Bio-Techne (TECH), Agilent Technologies (A), and Bio-Rad Laboratories (BIO).

How does Mettler-Toledo International compare to Bruker?

Bruker (NASDAQ:BRKR) and Mettler-Toledo International (NYSE:MTD) are both life sciences tools & services companies, but which is the superior investment? We will contrast the two companies based on the strength of their analyst recommendations, media sentiment, institutional ownership, valuation, earnings, risk, profitability and dividends.

In the previous week, Bruker had 4 more articles in the media than Mettler-Toledo International. MarketBeat recorded 15 mentions for Bruker and 11 mentions for Mettler-Toledo International. Mettler-Toledo International's average media sentiment score of 1.27 beat Bruker's score of 1.18 indicating that Mettler-Toledo International is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Bruker	10 Very Positive mention(s)	0 Positive mention(s)	4 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Mettler-Toledo International	9 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Mettler-Toledo International has a net margin of 21.40% compared to Bruker's net margin of -0.65%. Bruker's return on equity of 11.60% beat Mettler-Toledo International's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Bruker	-0.65%	11.60%	4.25%
Mettler-Toledo International	21.40%	-622.80%	24.97%

79.5% of Bruker shares are owned by institutional investors. Comparatively, 95.1% of Mettler-Toledo International shares are owned by institutional investors. 27.2% of Bruker shares are owned by insiders. Comparatively, 0.7% of Mettler-Toledo International shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth.

Mettler-Toledo International has higher revenue and earnings than Bruker. Bruker is trading at a lower price-to-earnings ratio than Mettler-Toledo International, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Bruker	$3.44B	2.79	-$8.60M	-$0.24	N/A
Mettler-Toledo International	$4.03B	6.99	$869.19M	$42.64	32.66

Bruker has a beta of 1.29, indicating that its share price is 29% more volatile than the broader market. Comparatively, Mettler-Toledo International has a beta of 1.24, indicating that its share price is 24% more volatile than the broader market.

Bruker currently has a consensus price target of $56.79, indicating a potential downside of 9.73%. Mettler-Toledo International has a consensus price target of $1,408.55, indicating a potential upside of 1.15%. Given Mettler-Toledo International's stronger consensus rating and higher probable upside, analysts plainly believe Mettler-Toledo International is more favorable than Bruker.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Bruker	2 Sell rating(s)	6 Hold rating(s)	7 Buy rating(s)	1 Strong Buy rating(s)	2.44
Mettler-Toledo International	0 Sell rating(s)	7 Hold rating(s)	6 Buy rating(s)	0 Strong Buy rating(s)	2.46

Summary

Mettler-Toledo International beats Bruker on 11 of the 17 factors compared between the two stocks.

How does Mettler-Toledo International compare to Repligen?

Repligen (NASDAQ:RGEN) and Mettler-Toledo International (NYSE:MTD) are both medical companies, but which is the superior stock? We will contrast the two businesses based on the strength of their institutional ownership, media sentiment, earnings, risk, analyst recommendations, profitability, dividends and valuation.

Repligen has a beta of 1.06, suggesting that its stock price is 6% more volatile than the broader market. Comparatively, Mettler-Toledo International has a beta of 1.24, suggesting that its stock price is 24% more volatile than the broader market.

Repligen currently has a consensus price target of $165.36, suggesting a potential upside of 13.77%. Mettler-Toledo International has a consensus price target of $1,408.55, suggesting a potential upside of 1.15%. Given Repligen's stronger consensus rating and higher probable upside, research analysts clearly believe Repligen is more favorable than Mettler-Toledo International.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Repligen	1 Sell rating(s)	2 Hold rating(s)	12 Buy rating(s)	2 Strong Buy rating(s)	2.88
Mettler-Toledo International	0 Sell rating(s)	7 Hold rating(s)	6 Buy rating(s)	0 Strong Buy rating(s)	2.46

97.6% of Repligen shares are owned by institutional investors. Comparatively, 95.1% of Mettler-Toledo International shares are owned by institutional investors. 0.6% of Repligen shares are owned by company insiders. Comparatively, 0.7% of Mettler-Toledo International shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term.

Mettler-Toledo International has higher revenue and earnings than Repligen. Mettler-Toledo International is trading at a lower price-to-earnings ratio than Repligen, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Repligen	$763.34M	10.74	$48.89M	$0.90	161.49
Mettler-Toledo International	$4.03B	6.99	$869.19M	$42.64	32.66

In the previous week, Repligen had 29 more articles in the media than Mettler-Toledo International. MarketBeat recorded 40 mentions for Repligen and 11 mentions for Mettler-Toledo International. Mettler-Toledo International's average media sentiment score of 1.27 beat Repligen's score of 1.00 indicating that Mettler-Toledo International is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Repligen	22 Very Positive mention(s)	4 Positive mention(s)	10 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Positive
Mettler-Toledo International	9 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Mettler-Toledo International has a net margin of 21.40% compared to Repligen's net margin of 6.73%. Repligen's return on equity of 4.88% beat Mettler-Toledo International's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Repligen	6.73%	4.88%	3.48%
Mettler-Toledo International	21.40%	-622.80%	24.97%

Summary

Repligen beats Mettler-Toledo International on 9 of the 17 factors compared between the two stocks.

How does Mettler-Toledo International compare to Bio-Techne?

Mettler-Toledo International (NYSE:MTD) and Bio-Techne (NASDAQ:TECH) are both large-cap medical companies, but which is the better business? We will contrast the two companies based on the strength of their media sentiment, dividends, analyst recommendations, earnings, institutional ownership, profitability, valuation and risk.

95.1% of Mettler-Toledo International shares are held by institutional investors. Comparatively, 99.0% of Bio-Techne shares are held by institutional investors. 0.7% of Mettler-Toledo International shares are held by insiders. Comparatively, 1.3% of Bio-Techne shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.

In the previous week, Bio-Techne had 4 more articles in the media than Mettler-Toledo International. MarketBeat recorded 15 mentions for Bio-Techne and 11 mentions for Mettler-Toledo International. Bio-Techne's average media sentiment score of 1.41 beat Mettler-Toledo International's score of 1.27 indicating that Bio-Techne is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Mettler-Toledo International	9 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Bio-Techne	12 Very Positive mention(s)	1 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Mettler-Toledo International has a net margin of 21.40% compared to Bio-Techne's net margin of 9.05%. Bio-Techne's return on equity of 13.57% beat Mettler-Toledo International's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Mettler-Toledo International	21.40%	-622.80%	24.97%
Bio-Techne	9.05%	13.57%	10.66%

Mettler-Toledo International has higher revenue and earnings than Bio-Techne. Mettler-Toledo International is trading at a lower price-to-earnings ratio than Bio-Techne, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Mettler-Toledo International	$4.03B	6.99	$869.19M	$42.64	32.66
Bio-Techne	$1.22B	9.25	$73.40M	$0.69	104.45

Mettler-Toledo International has a beta of 1.24, indicating that its stock price is 24% more volatile than the broader market. Comparatively, Bio-Techne has a beta of 1.29, indicating that its stock price is 29% more volatile than the broader market.

Mettler-Toledo International currently has a consensus target price of $1,408.55, suggesting a potential upside of 1.15%. Bio-Techne has a consensus target price of $68.08, suggesting a potential downside of 5.54%. Given Mettler-Toledo International's stronger consensus rating and higher probable upside, equities research analysts clearly believe Mettler-Toledo International is more favorable than Bio-Techne.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Mettler-Toledo International	0 Sell rating(s)	7 Hold rating(s)	6 Buy rating(s)	0 Strong Buy rating(s)	2.46
Bio-Techne	1 Sell rating(s)	13 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.12

Summary

Mettler-Toledo International and Bio-Techne tied by winning 8 of the 16 factors compared between the two stocks.

How does Mettler-Toledo International compare to Agilent Technologies?

Agilent Technologies (NYSE:A) and Mettler-Toledo International (NYSE:MTD) are both large-cap medical companies, but which is the better business? We will compare the two companies based on the strength of their valuation, institutional ownership, analyst recommendations, dividends, earnings, profitability, risk and media sentiment.

95.1% of Mettler-Toledo International shares are held by institutional investors. 0.7% of Mettler-Toledo International shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.

Agilent Technologies currently has a consensus price target of $159.35, suggesting a potential upside of 13.36%. Mettler-Toledo International has a consensus price target of $1,408.55, suggesting a potential upside of 1.15%. Given Agilent Technologies' stronger consensus rating and higher possible upside, research analysts plainly believe Agilent Technologies is more favorable than Mettler-Toledo International.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Agilent Technologies	0 Sell rating(s)	4 Hold rating(s)	13 Buy rating(s)	2 Strong Buy rating(s)	2.89
Mettler-Toledo International	0 Sell rating(s)	7 Hold rating(s)	6 Buy rating(s)	0 Strong Buy rating(s)	2.46

In the previous week, Agilent Technologies had 9 more articles in the media than Mettler-Toledo International. MarketBeat recorded 20 mentions for Agilent Technologies and 11 mentions for Mettler-Toledo International. Mettler-Toledo International's average media sentiment score of 1.27 beat Agilent Technologies' score of 1.26 indicating that Mettler-Toledo International is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Agilent Technologies	14 Very Positive mention(s)	3 Positive mention(s)	2 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Positive
Mettler-Toledo International	9 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Mettler-Toledo International has a net margin of 21.40% compared to Agilent Technologies' net margin of 19.55%. Agilent Technologies' return on equity of 24.33% beat Mettler-Toledo International's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Agilent Technologies	19.55%	24.33%	12.99%
Mettler-Toledo International	21.40%	-622.80%	24.97%

Agilent Technologies has higher revenue and earnings than Mettler-Toledo International. Agilent Technologies is trading at a lower price-to-earnings ratio than Mettler-Toledo International, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Agilent Technologies	$6.95B	5.71	$1.30B	$4.98	28.23
Mettler-Toledo International	$4.03B	6.99	$869.19M	$42.64	32.66

Agilent Technologies has a beta of 1.25, meaning that its stock price is 25% more volatile than the broader market. Comparatively, Mettler-Toledo International has a beta of 1.24, meaning that its stock price is 24% more volatile than the broader market.

Summary

Agilent Technologies beats Mettler-Toledo International on 9 of the 17 factors compared between the two stocks.

How does Mettler-Toledo International compare to Bio-Rad Laboratories?

Bio-Rad Laboratories (NYSE:BIO) and Mettler-Toledo International (NYSE:MTD) are both medical companies, but which is the better stock? We will contrast the two companies based on the strength of their dividends, institutional ownership, valuation, analyst recommendations, media sentiment, risk, earnings and profitability.

Bio-Rad Laboratories presently has a consensus target price of $303.33, suggesting a potential downside of 8.63%. Mettler-Toledo International has a consensus target price of $1,408.55, suggesting a potential upside of 1.15%. Given Mettler-Toledo International's stronger consensus rating and higher probable upside, analysts clearly believe Mettler-Toledo International is more favorable than Bio-Rad Laboratories.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Bio-Rad Laboratories	2 Sell rating(s)	2 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	1.80
Mettler-Toledo International	0 Sell rating(s)	7 Hold rating(s)	6 Buy rating(s)	0 Strong Buy rating(s)	2.46

65.2% of Bio-Rad Laboratories shares are owned by institutional investors. Comparatively, 95.1% of Mettler-Toledo International shares are owned by institutional investors. 30.3% of Bio-Rad Laboratories shares are owned by insiders. Comparatively, 0.7% of Mettler-Toledo International shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term.

In the previous week, Mettler-Toledo International had 2 more articles in the media than Bio-Rad Laboratories. MarketBeat recorded 11 mentions for Mettler-Toledo International and 9 mentions for Bio-Rad Laboratories. Bio-Rad Laboratories' average media sentiment score of 1.34 beat Mettler-Toledo International's score of 1.27 indicating that Bio-Rad Laboratories is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Bio-Rad Laboratories	7 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Mettler-Toledo International	9 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Bio-Rad Laboratories has a beta of 1.08, meaning that its stock price is 8% more volatile than the broader market. Comparatively, Mettler-Toledo International has a beta of 1.24, meaning that its stock price is 24% more volatile than the broader market.

Mettler-Toledo International has higher revenue and earnings than Bio-Rad Laboratories. Mettler-Toledo International is trading at a lower price-to-earnings ratio than Bio-Rad Laboratories, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Bio-Rad Laboratories	$2.58B	3.44	$759.90M	$6.07	54.69
Mettler-Toledo International	$4.03B	6.99	$869.19M	$42.64	32.66

Mettler-Toledo International has a net margin of 21.40% compared to Bio-Rad Laboratories' net margin of 6.52%. Bio-Rad Laboratories' return on equity of 3.56% beat Mettler-Toledo International's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Bio-Rad Laboratories	6.52%	3.56%	2.49%
Mettler-Toledo International	21.40%	-622.80%	24.97%

Summary

Mettler-Toledo International beats Bio-Rad Laboratories on 12 of the 16 factors compared between the two stocks.

Get Mettler-Toledo International News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding MTD and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

MTD vs. The Competition

Export

Metric	Mettler-Toledo International	MED INSTRUMENTS Industry	Medical Sector	NYSE Exchange
Market Cap	$27.00B	$7.54B	$7.08B	$23.66B
Dividend Yield	N/A	1.30%	2.66%	4.21%
P/E Ratio	32.66	48.08	27.24	31.08
Price / Sales	6.99	96.94	520.20	14.27
Price / Cash	26.92	25.93	49.60	31.92
Price / Book	-1,200.50	7.05	10.24	4.83
Net Income	$869.19M	$162.27M	$3.60B	$1.07B
7 Day Performance	8.29%	0.45%	-0.96%	0.69%
1 Month Performance	10.62%	-3.56%	-3.60%	0.89%
1 Year Performance	10.00%	4.39%	20.54%	15.67%

Mettler-Toledo International Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
MTD Mettler-Toledo International	2.3363 of 5 stars	$1,392.58 +4.2%	$1,408.55 +1.1%	+10.6%	$27.00B	$4.03B	32.66	18,100	Positive News Upcoming Earnings Gap Up
BRKR Bruker	2.6033 of 5 stars	$56.17 -3.5%	$56.79 +1.1%	+43.2%	$8.86B	$3.44B	N/A	11,085	News Coverage Positive News Upcoming Earnings
RGEN Repligen	3.8678 of 5 stars	$145.49 -1.2%	$165.00 +13.4%	+21.5%	$8.31B	$738.26M	161.66	2,000	Trending News Earnings Report
TECH Bio-Techne	2.6899 of 5 stars	$71.64 -0.7%	$68.08 -5.0%	+23.1%	$11.29B	$1.22B	103.83	3,100	News Coverage Positive News Upcoming Earnings
A Agilent Technologies	4.7361 of 5 stars	$130.55 -0.7%	$159.35 +22.1%	+17.6%	$37.13B	$6.95B	26.21	18,100	Positive News Upcoming Earnings

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NYSE:MTD) was last updated on 7/29/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Mettler-Toledo International (MTD) Competitors

MTD vs. BRKR, RGEN, TECH, A, and BIO

How does Mettler-Toledo International compare to Bruker?

Summary

How does Mettler-Toledo International compare to Repligen?

Summary

How does Mettler-Toledo International compare to Bio-Techne?

Summary

How does Mettler-Toledo International compare to Agilent Technologies?

Summary

How does Mettler-Toledo International compare to Bio-Rad Laboratories?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

MTD vs. The Competition

Mettler-Toledo International Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Mettler-Toledo International (MTD) Competitors

MTD vs. BRKR, RGEN, TECH, A, and BIO

How does Mettler-Toledo International compare to Bruker?

Does the media prefer BRKR or MTD?

Is BRKR or MTD more profitable?

Do institutionals and insiders believe in BRKR or MTD?

Which has stronger valuation and earnings, BRKR or MTD?

Which has more volatility & risk, BRKR or MTD?

Do analysts recommend BRKR or MTD?

Summary

How does Mettler-Toledo International compare to Repligen?

Which has more volatility & risk, RGEN or MTD?

Do analysts rate RGEN or MTD?

Do institutionals & insiders hold more shares of RGEN or MTD?

Which has better earnings & valuation, RGEN or MTD?

Does the media prefer RGEN or MTD?

Is RGEN or MTD more profitable?

Summary

How does Mettler-Toledo International compare to Bio-Techne?

Do institutionals and insiders have more ownership in MTD or TECH?

Does the media refer more to MTD or TECH?

Is MTD or TECH more profitable?

Which has stronger valuation & earnings, MTD or TECH?

Which has more volatility and risk, MTD or TECH?

Do analysts rate MTD or TECH?

Summary

How does Mettler-Toledo International compare to Agilent Technologies?

Do institutionals & insiders have more ownership in A or MTD?

Do analysts prefer A or MTD?

Does the media refer more to A or MTD?

Is A or MTD more profitable?

Which has higher earnings & valuation, A or MTD?

Which has more risk and volatility, A or MTD?

Summary

How does Mettler-Toledo International compare to Bio-Rad Laboratories?

Do analysts prefer BIO or MTD?

Do insiders & institutionals have more ownership in BIO or MTD?

Does the media prefer BIO or MTD?

Which has more volatility and risk, BIO or MTD?

Which has preferable valuation & earnings, BIO or MTD?

Is BIO or MTD more profitable?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

MTD vs. The Competition

Mettler-Toledo International Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools